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Hematopoietic stem cells (HSCs) consist of a small cell-
population in the bone-marrow (BM) that are 
responsible for lifelong production of all mature blood 
cells in an organism. A delicate balance of different 
HSC fates, namely, quiescence, self-renewal and 
differentiation is decisive in maintaining the HSC pool 
and blood cell homeostasis. Cellular metabolism has 
emerged as one of the fundamental regulators of HSC 
fate decision process. HSCs rely primarily on anaerobic 
glycolysis while downstream progenitors use mito-
chondrial metabolism to fulfil their energy requirements 
[1]. This distinct metabolic state protects the HSCs from 
cellular damage inflicted by reactive oxygen species 
produced by active mitochondria, thereby maintaining 
their long-term in vivo function [2] and possibly driving 
epigenetic modifications orchestrating HSCs fate 
determination. We and others, have previously shown 
that low mitochondrial activity is a hallmark of 
functional HSCs [1, 3, 4]. Additionally, we have 
demonstrated low mitochondrial activity as conditio-
sine-qua-non required by HSCs undergoing self-
renewing divisions in ex-vivo cultures [3].  
In a recent study we have tested the mitochondrial 
modulator and NAD+ boosting agent, Nicotinamide 
Riboside (NR), in the context of regenerative hemato-
poiesis [5]. NR, together with nicotinic acid and 
nicotinamide, belongs to the vitamin B3 family and, 
differently from other analogs, NR, enters the NAD 
salvage pathway through its conversion into nicotine-
mononucleotide (NMN) accomplished by the substrate-
specific enzyme NR kinase (NRK). One week of NR 
dietary supplementation to wild type mice resulted in 
increased BM cellularity and expansion of hemato-
poietic progenitor cells, this reflected in a significant 
increase in terminally differentiated circulating blood 
and immune cells. Importantly, mitochondrial profiling 
of HSCs derived from mice supplemented with NR 
revealed significant reduction of mitochondrial mem-
brane potential (an indirect readout on mitochondrial 
activity), indicating that NR has a direct effect on HSC 
metabolism when administered systemically. In order to 
examine if the effect of NR is cell autonomous, we 
exposed BM derived HSCs to NR in ex vivo cultures 
and found significant lowering of mitochondrial 
membrane potential (ΔΨm). Moreover, NR effectively 
reduced ΔΨm of fetal liver, cord-blood and adult aged 
BM-derived human HSCs, in a dose-dependent manner. 







Accordingly, in line with our previous published data 
[3], NR-induced reduction of human HSC ΔΨm 
reflected in an amelioration of their long-term human 
blood reconstitution capability.  
To understand the molecular mechanisms driving the 
effect of NR, we performed transcriptome analysis (by 
RNA sequencing) on ex vivo cultured HSCs. We found 
upregulation of autophagy (and mitophagy) and of 
NAD salvage pathway genes upon NR treatment, and a 
concomitant downregulation of mitochondrial meta-
bolism pathway genes (TCA cycle and Oxidative 
Phosphorylation). NR-induced mitophagy was 
confirmed by image analysis of in vitro cultured HSCs 
and by bone marrow analysis of mitophagy reporter 
mice (mito-QC). Importantly, the use of Mito-QC mice 
evidenced that NR exerts a direct effect on the most 
primitive hematopoietic compartment when the 
compound is administered systemically in the diet. We 
discovered that mitophagy induction was coupled with 
activation of mitochondrial unfolded protein response 
(UPRmt), that has been recently proposed as a 
conservation mechanism of HSCs pool during aging [6]. 
We hypothesize that NR-induced mitochondrial stress 
leads to the clearance of damaged mitochondria unable 
to coop with the metabolic stress. This complex 
mechanism initiates an instruction process where cells 
are primed toward asymmetric self-renewing cell 
division via differential distribution of active mito-
chondria in daughter cells.  
Importantly, the resulting hematopoietic progenitor 
expansion occurring in mice supplemented with NR has 
critical clinical implications. Indeed, 20% of patients 
undergoing bone marrow transplantation die because of 
delay in blood and immune recovery. Given the 
dependency of blood and immune cell production on 
hematopoietic progenitor function, we asked if NR 
could boost hematopoietic recovery post BM trans-
plantation and shorten the period of aplasia. In limiting 
cell dose transplantation setting, the control mice did 
not survive more than 4 weeks, while 80% of NR fed 
did. We found that this improved survival was due to a 
faster exit from neutropenia and thrombocytopenia in 
NR fed mice. Moreover, using Mito-QC mice, we 
demonstrated that under conditions of hematopoietic 
stress (transplantation), NR diet supplementation 
strongly induces mitophagy in hematopoietic stem and 
progenitor cells. These data indicate that mitophagy 
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processes are both critical in homeostatic situation and 
in stress hematopoiesis context. 
Given that previous studies have implicated the 
importance of mitophagy and autophagy in HSC 
function and aging [7, 8] and our own finding showing 
that short ex vivo exposure to NR lowers ΔΨm in aged 
human HSCs, we believe that NAD boosting strategies 
could be used to improve functionality of the hemato-
poietic stem cell pool in elderly, where HSCs lose their 
capacity to produce a balanced immune system being 
strongly primed toward a myeloid fate (myeloid bias). 
Moreover, similar strategies could be employed in the 
context of myelodysplastic syndromes where hemato-
poietic defects are in certain cases associated with HSC 
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